Follow
Samuel Jones
Samuel Jones
Lecturer and Post-doctoral Research Associate, Cardiff University
Verified email at cardiff.ac.uk
Title
Cited by
Cited by
Year
Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL
R French, O Hayward, S Jones, W Yang, R Clarkson
Molecular cancer 14, 1-13, 2015
292015
The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer
S Jones, G Farr, T Nimmanon, S Ziliotto, JMW Gee, KM Taylor
Exploration of targeted anti-tumor therapy 3 (2), 224, 2022
112022
The discovery of new and more potent chloropyramine (C4) analogues for the potential treatment of invasive breast cancer
S Kandil, F Prencipe, S Jones, S Hiscox, AD Westwell
Chemical Biology & Drug Design 91 (1), 314-321, 2018
102018
Structure-based virtual screening, synthesis and biological evaluation of potential FAK-FAT domain inhibitors for treatment of metastatic cancer
SB Kandil, SR Jones, S Smith, SE Hiscox, AD Westwell
Molecules 25 (15), 3488, 2020
92020
Exploring Focal Adhesion Kinase (FAK) as a therapeutic target in triple negative breast cancer
SR Jones
Cardiff University, 2017
12017
Methods to visualise zinc transporter proteins of the SLC39A family in cells
G Farr, S Jones, KM Taylor
Methods in Enzymology 687, 67-85, 2023
2023
Characterizing the cellular uptake of neural stem-cell derived exosomes using live-cell imaging techniques
Jones, Samuel: Caws, Thomas: Hayes, Anthony: Durban, Victoria Marsh ...
ISEV annual meeting 2019 8, 129, 2019
2019
Targeting metastasis and cancer stem-like cells in triple negative breast cancer through inhibition of focal adhesion kinase
S Jones, C Smith, S Hiscox, WG Jiang
Cancer Research 76 (14_Supplement), 4125-4125, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–8